Article
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
2021-09-22
Abstract excerpt
<h4>Background</h4> Following emergency use authorization in December 2020, the Coronavirus Efficacy (COVE) trial was amended to an open-label phase, where participants were unblinded and those randomized to placebo were offered vaccination. Emergence of the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with increased incidences of coronavirus disease 2019 (Covid...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d5fd9cab-4352-5a3c-96a6-63355ac1bbc6
- DOI
- 10.1101/2021.09.17.21263624
